{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:28:52Z","timestamp":1791340132251,"version":"4.3.1"},"reference-count":50,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Philadelphia chromosome\u2013negative myeloproliferative neoplasms (MPNs) are clonal myeloid disorders with increased production of terminally differentiated cells. The disease course is generally chronic, but some patients show disease progression (secondary myelofibrosis or accelerated phase) and\/or leukemic transformation. We investigated chromosomal aberrations in 408 MPN samples using high-resolution single-nucleotide polymorphism microarrays to identify disease-associated somatic lesions. Of 408 samples, 37.5% had a wild-type karyotype and 62.5% harbored at least 1 chromosomal aberration. We identified 25 recurrent aberrations that were found in 3 or more samples. An increased number of chromosomal lesions was significantly associated with patient age, as well as with disease progression and leukemic transformation, but no association was observed with MPN subtypes, Janus kinase 2 (JAK2) mutational status, or disease duration. Aberrations of chromosomes 1q and 9p were positively associated with disease progression to secondary myelofibrosis or accelerated phase. Changes of chromosomes 1q, 7q, 5q, 6p, 7p, 19q, 22q, and 3q were positively associated with post-MPN acute myeloid leukemia. We mapped commonly affected regions to single target genes on chromosomes 3p (forkhead box P1 [FOXP1]), 4q (tet oncogene family member 2 [TET2]), 7p (IKAROS family zinc finger 1 [IKZF1]), 7q (cut-like homeobox 1 [CUX1]), 12p (ets variant 6 [ETV6]), and 21q (runt-related transcription factor 1 [RUNX1]). Our data provide insight into the genetic complexity of MPNs and implicate new genes involved in disease progression.<\/jats:p>","DOI":"10.1182\/blood-2011-01-331678","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:12:50Z","timestamp":1304208770000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":168,"title":["Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression"],"prefix":"10.1182","volume":"118","author":[{"given":"Thorsten","family":"Klampfl","sequence":"first","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashot","family":"Harutyunyan","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Berg","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Gisslinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schalling","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Bagienski","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damla","family":"Olcaydu","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Azienda Ospedaliera Universitaria Fondazione Macchi, Varese, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Rumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pietra","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"J\u00e4ger","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pieri","sequence":"additional","affiliation":[{"name":"Section of Hematology, University of Florence, Florence, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Guglielmelli","sequence":"additional","affiliation":[{"name":"Section of Hematology, University of Florence, Florence, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Iacobucci","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncological Sciences L. and A. Seragnoli, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncological Sciences L. and A. Seragnoli, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro M.","family":"Vannucchi","sequence":"additional","affiliation":[{"name":"Section of Hematology, University of Florence, Florence, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Gisslinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kralovics","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;"},{"name":"Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"23","key":"2019111807372391400_B1","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders.","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"issue":"33","key":"2019111807372391400_B2","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1200\/JCO.2009.22.8833","article-title":"Dynamic model for predicting death within 12 months in patients with primary or post-polycythemia vera\/essential thrombocythemia myelofibrosis.","volume":"27","author":"Tam","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111807372391400_B3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0609.2008.01163.x","article-title":"AML transformation in 56 patients with Ph- MPD in two well defined populations.","volume":"82","author":"Abdulkarim","year":"2009","journal-title":"Eur J Haematol"},{"issue":"5","key":"2019111807372391400_B4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2009.01224.x","article-title":"Conventional cytogenetics in myelofibrosis: literature review and discussion.","volume":"82","author":"Hussein","year":"2009","journal-title":"Eur J Haematol"},{"issue":"1","key":"2019111807372391400_B5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0609.2009.01246.x","article-title":"Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.","volume":"83","author":"Gangat","year":"2009","journal-title":"Eur J Haematol"},{"issue":"1","key":"2019111807372391400_B6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2007.02.009","article-title":"Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.","volume":"255","author":"Panani","year":"2007","journal-title":"Cancer Lett"},{"issue":"3","key":"2019111807372391400_B7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-0609.2007.01003.x","article-title":"Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates.","volume":"80","author":"Gangat","year":"2008","journal-title":"Eur J Haematol"},{"issue":"10","key":"2019111807372391400_B8","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/leu.2008.218","article-title":"Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs).","volume":"22","author":"Reilly","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"2019111807372391400_B9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera.","volume":"30","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"issue":"9464","key":"2019111807372391400_B10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"7037","key":"2019111807372391400_B11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"17","key":"2019111807372391400_B12","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders.","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807372391400_B13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"10","key":"2019111807372391400_B14","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"issue":"3","key":"2019111807372391400_B15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/leu.2008.249","article-title":"UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.","volume":"23","author":"Szpurka","year":"2009","journal-title":"Leukemia"},{"issue":"2","key":"2019111807372391400_B16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0609.2008.01183.x","article-title":"Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis.","volume":"82","author":"Buxhofer-Ausch","year":"2009","journal-title":"Eur J Haematol"},{"issue":"22","key":"2019111807372391400_B17","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers.","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111807372391400_B18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/leu.2009.47","article-title":"TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"issue":"24","key":"2019111807372391400_B19","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1158\/0008-5472.CAN-08-2754","article-title":"250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.","volume":"68","author":"Dunbar","year":"2008","journal-title":"Cancer Res"},{"issue":"7257","key":"2019111807372391400_B20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","article-title":"Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.","volume":"460","author":"Sanada","year":"2009","journal-title":"Nature"},{"issue":"11","key":"2019111807372391400_B21","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/leu.2009.141","article-title":"Mutations of ASXL1 gene in myeloproliferative neoplasms.","volume":"23","author":"Carbuccia","year":"2009","journal-title":"Leukemia"},{"issue":"4","key":"2019111807372391400_B22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMc0910063","article-title":"Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms.","volume":"362","author":"Green","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111807372391400_B23","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/leu.2010.99","article-title":"Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.","volume":"24","author":"J\u00e4ger","year":"2010","journal-title":"Leukemia"},{"issue":"14","key":"2019111807372391400_B24","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2009-07-235119","article-title":"Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.","volume":"115","author":"Thoennissen","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111807372391400_B25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3324\/haematol.2009.013623","article-title":"High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations.","volume":"95","author":"Stegelmann","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"2019111807372391400_B26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2005-11-009605","article-title":"Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.","volume":"108","author":"Kralovics","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111807372391400_B27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1525-1578(10)60458-8","article-title":"Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex PCR and capillary electrophoresis assay.","volume":"5","author":"Murphy","year":"2003","journal-title":"J Mol Diagn"},{"issue":"5","key":"2019111807372391400_B28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMc1012718","article-title":"p53 lesions in leukemic transformation.","volume":"364","author":"Harutyunyan","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111807372391400_B29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"2019111807372391400_B30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"issue":"6","key":"2019111807372391400_B31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2010-02-270108","article-title":"Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.","volume":"116","author":"Oh","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111807372391400_B32","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/leu.2010.163","article-title":"LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.","volume":"24","author":"Pardanani","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"2019111807372391400_B33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2008-02-130435","article-title":"Whole genome scanning as a cytogenetic tool in hematologic malignancies.","volume":"112","author":"Maciejewski","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2019111807372391400_B34","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2008-01-134114","article-title":"JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders.","volume":"112","author":"Plo","year":"2008","journal-title":"Blood"},{"issue":"7145","key":"2019111807372391400_B35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature05862","article-title":"Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age.","volume":"447","author":"Rossi","year":"2007","journal-title":"Nature"},{"issue":"3","key":"2019111807372391400_B36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2006-12-064287","article-title":"Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.","volume":"110","author":"Vannucchi","year":"2007","journal-title":"Blood"},{"issue":"7115","key":"2019111807372391400_B37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature05194","article-title":"Inactivation of the p53 pathway in retinoblastoma.","volume":"444","author":"Laurie","year":"2006","journal-title":"Nature"},{"issue":"6","key":"2019111807372391400_B38","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.11023","article-title":"Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target.","volume":"104","author":"Riemenschneider","year":"2003","journal-title":"Int J Cancer"},{"issue":"14","key":"2019111807372391400_B39","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2009-08-236596","article-title":"Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.","volume":"115","author":"Beer","year":"2010","journal-title":"Blood"},{"issue":"19","key":"2019111807372391400_B40","doi-asserted-by":"crossref","first-page":"9492","DOI":"10.1158\/0008-5472.CAN-05-4230","article-title":"Transgenic mice expressing the p75 CCAAT-displacement protein\/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia.","volume":"66","author":"Cadieux","year":"2006","journal-title":"Cancer Res"},{"issue":"10","key":"2019111807372391400_B41","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/MCB.02089-07","article-title":"p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.","volume":"28","author":"Truscott","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"24","key":"2019111807372391400_B42","first-page":"8820","article-title":"The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.","volume":"61","author":"Banham","year":"2001","journal-title":"Cancer Res"},{"key":"2019111807372391400_B43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0065-230X(08)60096-2","article-title":"Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.","volume":"71","author":"Kok","year":"1997","journal-title":"Adv Cancer Res"},{"issue":"8","key":"2019111807372391400_B44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ni1358","article-title":"Foxp1 is an essential transcriptional regulator of B cell development.","volume":"7","author":"Hu","year":"2006","journal-title":"Nat Immunol"},{"issue":"2","key":"2019111807372391400_B45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"issue":"2","key":"2019111807372391400_B46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/gcc.1127","article-title":"Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.","volume":"31","author":"Odero","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"2019111807372391400_B47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semcancer.2005.01.008","article-title":"ETV6: a versatile player in leukemogenesis.","volume":"15","author":"Bohlander","year":"2005","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"2019111807372391400_B48","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.leu.2400798","article-title":"ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia.","volume":"11","author":"Cav\u00e9","year":"1997","journal-title":"Leukemia"},{"issue":"25","key":"2019111807372391400_B49","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1182\/blood-2009-06-223982","article-title":"AML1\/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms.","volume":"114","author":"Ding","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111807372391400_B50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/j.1460-2075.1995.tb07008.x","article-title":"An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms.","volume":"14","author":"Tanaka","year":"1995","journal-title":"EMBO J"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/1\/167\/1340331\/zh802711000167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/1\/167\/1340331\/zh802711000167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T12:45:54Z","timestamp":1574081154000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/1\/167\/28426\/Genome-integrity-of-myeloproliferative-neoplasms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-331678","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,7]]}}}